Glutathione-sensitive Mesoporous Nanoparticles Loaded with Cinnamaldehyde for Chemodynamic and Immunological Therapy of Cancer
Lichong Zhu,Wenyue Li,Chuang Liu,Saisai Yue,Yuanyuan Qiao,Yingying Cui,Junwei Cheng,Ming Zhang,Peisen Zhang,Beibei Zhang,Yi Hou
DOI: https://doi.org/10.1039/d3tb01094e
IF: 7.571
2023-08-17
Journal of Materials Chemistry B
Abstract:Chemodynamic therapy as a novel type of chemotherapies can damage the DNA structures and induce cell apoptosis and immunogenic cell death (ICD) through generating reactive oxygen species (ROS) to aggravate oxidative stress. Nonetheless, as an intrinsic antioxidative response of tumor cells, the expression of glutathione (GSH) can be upregulated to maintain the cellular redox balance and protect the tumor cells from ROS-mediated damage. In this context, it is feasibly to simultaneous boost ROS generation and GSH depletion in tumor cells, however, the precise delivery and release of GSH scavengers at specitic subcellular sites is of great importance. Herein, we propose a GSH-responsive mesoporous organosilica nanoparticles (MONs)-based nanomedicine MON-CA-TPP@HA through sequentially covalently attaching Triphenylphosphine (TPP) and electrostatic coating hyaluronic acid (HA) onto the surface of cinnamaldehyde (CA) loaded MONs, known as MON-CA-TPP@HA, which has been demonstrated to be an extremely effective therapeutic strategy for cancer treatment through inducing ICD and apoptosis of breast cancer cells. Systematic in vitro experimental results clearly revealed that the nanomedicines can actively target the tumor cells with the help of HA, subsequently entering the tumor cells, and precisely binding with the mitochondria through TPP residues. Upon the cleavage of the disulfide bond in the MONs triggered by over-expressed GSH within tumor, the CA molecules can be released and induce the excessive ROS in situ surrounding the mitochondria to activate oxidative stress to induce apoptosis and ICD of breast cancer cells. The results in vivo experiments confirm that the MON-CA-TPP@HA nanomedicine can effectively promote DCs maturation, CD 8+ T cells activation, and improve the ratio of M1/M2 macrophages which improve tumor immunosuppressive microenvironment. It is thus believed that the current nanomedicines have paved a new way for the future cancer therapy.
materials science, biomaterials